Pulmonx Corporation Common Stock (NASDAQ: LUNG) last traded at $2.26, down 1.74% on the session. The quote above updates while this page is open; the figures below are drawn from Pulmonx Corporation Common Stock’s own filings and are restated only when a new one is published.
Pulmonx Corporation Common Stock trades on NASDAQ under the ticker LUNG. Its market capitalisation is $97.06 million.
Valuation measures for Pulmonx Corporation Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $97.06M |
|---|---|
| Enterprise value | $116.76M |
| Price / sales | 1.11 |
| Price / book | 2.48 |
| Beta | 2.18 |
Trailing-twelve-month figures tagged in Pulmonx Corporation Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $87.44M |
|---|---|
| Net income (TTM) | -$48.12M |
| EPS (TTM) | -$1.16 |
| Gross margin | 77.06% |
| Operating margin | -52.96% |
| Return on equity | -122.76% |
| Cash | $55.84M |
Range and volume for LUNG over the past 52 weeks.
| 52-week high | $2.89 |
|---|---|
| 52-week low | $1.13 |
| Volume | 610.1K |
| Average volume | 574.3K |
| Previous close | $2.30 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.